WO2025151471A1

WO2025151471A1 - Apparatus, system, and method for controlled substance wasting

Info

Publication number: WO2025151471A1
Application number: PCT/US2025/010670
Authority: WO
Inventors: Austin J. MCKINNON; Erik Kurt Witt; Christopher Biagioli
Original assignee: Becton Dickinson and Co
Current assignee: Becton Dickinson and Co
Priority date: 2024-01-09
Filing date: 2025-01-08
Publication date: 2025-07-17
Anticipated expiration: 2026-07-09

Abstract

An apparatus for controlled substance wasting may include a fluid injection port, at least one sensor, communication circuitry, and/or at least one processor. The fluid injection port may be configured to be connected to a syringe and receive a waste portion of a fluid from the syringe. The at least one sensor may be configured to capture wasting information associated with at least a wasted volume of the waste portion the fluid. The communication circuitry may be configured to communicate with an external computing system to receive an expected waste volume. The at least one processor may be configured to: determine, based on the wasting information, the wasted volume of the waste portion; determine, based on the wasted volume and the expected waste volume, whether the wasted volume corresponds to the expected waste volume; and/or provide an indication associated with receiving the waste portion of the fluid from the syringe.

Description

APPARATUS, SYSTEM, AND METHOD FOR CONTROLLED SUBSTANCE WASTING

CROSS-REFERENCE TO RELATED APPLICATION

[0001] The present application claims priority to United States Provisional Patent Application No. 63/619,037 entitled “Apparatus, System, and Method for Controlled Substance Wasting” filed January 9, 2024, the disclosure of which is hereby incorporated by reference in its entirety.

BACKGROUND

1. Technical Field

[0002] This disclosure relates generally to controlled substance wasting and, in nonlimiting embodiments or aspects, to apparatuses, systems, and methods for controlled substance wasting.

2. Technical Considerations

[0003] Existing wasting solutions may require a second human witness to verify volume and disposal, a separate neutralization and securement solution, manual transfer of drugs to cuvettes for analysis, and/or the like. Accordingly, there is a need for improved wasting solutions for controlled substances.

SUMMARY

[0004] Accordingly, provided are improved apparatuses, systems, and methods for controlled substance wasting.

[0005] According to non-limiting embodiments or aspects, provided is an apparatus including: a fluid injection port configured to be connected to a syringe and receive a waste portion of a fluid from the syringe; at least one sensor configured to capture wasting information associated with at least a wasted volume of the waste portion the fluid received from the syringe; communication circuitry configured to communicate with an external computing system to receive an expected waste volume of the waste portion of the fluid; and at least one processor coupled to a memory and configured to: determine, based on the wasting information, the wasted volume of the waste portion of the fluid received from the syringe; determine, based on the wasted volume and the expected waste volume, whether the wasted volume corresponds to the expected waste volume; and provide an indication associated with receiving the waste portion of the fluid from the syringe.

[0006] In some non-limiting embodiments or aspects, the at least one sensor includes an external image capture device configured to capture, as the wasting information, a series of images of a moveable component of the syringe when the syringe is connected to the fluid injection port, and wherein the at least one processor is configured to determine the wasted volume by: processing, using one or more computer vision techniques, the series of images of the moveable component of the syringe.

[0007] In some non-limiting embodiments or aspects, the at least one sensor includes a mass balance scale configured to capture, as the wasting information, a wasted mass measurement of the waste portion the fluid received from the syringe, and wherein the at least one processor is configured to determine the wasted volume by: applying a mass balancing equation to the wasted mass measurement and a known density of the fluid.

[0008] In some non-limiting embodiments or aspects, the wasting information is further associated with a wasted drug and a wasted drug concentration of the waste portion the fluid received from the syringe, wherein the communication circuitry is further configured to communicate with the external computing system to receive an expected drug and an expected drug concentration of the waste portion the fluid, and wherein the at least one processor is further configured to: determine, based on the wasting information, the wasted drug and the wasted drug concentration of the waste portion the fluid received from the syringe; determine, based on the wasted drug, the expected drug, the wasted drug concentration, and the expected drug concentration, whether the wasted drug corresponds to the expected drug and whether the wasted drug concentration corresponds to the expected drug concentration; and provide an indication of whether the wasted drug corresponds to the expected drug and an indication of whether the wasted drug concentration corresponds to the expected drug concentration.

[0009] In some non-limiting embodiments or aspects, the at least one sensor includes a spectroscopic sensor.

[0010] In some non-limiting embodiments or aspects, the apparatus further includes: a fluid path connected to the fluid injection port and including Raman spectroscopy head and a flowthrough-cell.

[0011] In some non-limiting embodiments or aspects, the apparatus further includes: a rotating or revolving element including a plurality of spectroscopy cuvettes spaced apart from each other around a circumference of the rotating or revolving element, wherein the rotating or revolving element is configured to rotate or revolve to introduce a spectroscopy cuvette of the plurality of spectroscopy cuvettes into the waste portion of the fluid received from the syringe. [0012] In some non-limiting embodiments or aspects, the at least one sensor includes an internal image capture device configured to capture an image of a test strip including a plurality of assays introduced into the waste portion of the fluid received from the syringe.

[0013] In some non-limiting embodiments or aspects, the plurality of assays includes at least one of the following: one or more assays associated with a presence of one or more drugs, one or more assays associated with one or more predetermined concentrations of the one or more drugs, one or more assays associated with a presence of one or more diluents, one or more assays associated with one or more predetermined concentrations of the one or more diluents, or any combination thereof.

[0014] In some non-limiting embodiments or aspects, the plurality of assays includes at least one of the following: a plurality of first assays associated with a plurality of different concentrations of a same drug, a plurality of second assays associated with a presence or one or more predetermined concentrations of a plurality of different drugs, a plurality of third assays associated with a plurality of different concentrations of a same diluent, a plurality of fourth assays associated with a presence or one or more predetermined concentrations of a plurality of different diluents, or any combination thereof.

[0015] In some non-limiting embodiments or aspects, the apparatus further includes: a rotating or revolving element including a plurality of test strips spaced apart from each other around a circumference of the rotating or revolving element, wherein the rotating or revolving element is configured to rotate or revolve to introduce the test strip into the waste portion of the fluid received from the syringe.

[0016] In some non-limiting embodiments or aspects, the apparatus further includes: a pick roller configured to move the test strip from a top of a stack of test strips to introduce the test trip into the waste portion of the fluid received from the syringe.

[0017] In some non-limiting embodiments or aspects, the apparatus further includes: a RFID reader configured to read syringe information stored on a RFID tag on the syringe.

[0018] In some non-limiting embodiments or aspects, the apparatus further includes: a lockable housing, wherein the fluid injection port delivers the waste portion of the fluid received from the syringe to an interior of the lockable housing.

[0019] In some non-limiting embodiments or aspects, the lockable housing further includes a neutralizing agent configured to neutralize the fluid. [0020] In some non-limiting embodiments or aspects, the apparatus further includes: user interface configured to receive user input from a user, wherein the at least one processor is configured to control the user interface to provide the indication associated with receiving the waste portion of the fluid from the syringe.

[0021] In some non-limiting embodiments or aspects, the at least one processor is configured to control the communication circuitry to provide, to the external computing system, the indication associated with receiving the waste portion of the fluid from the syringe, and wherein the indication associated with receiving the waste portion of the fluid from the syringe includes an indication associated with whether the wasted volume corresponds to the expected waste volume.

[0022] According to some non-limiting embodiments or aspects, provided is a system, including: a flow sensor configured to measure a delivered volume of a delivery portion of a fluid delivered from a syringe to a fluid pathway that provides the fluid to a patient and provide, based on the delivered volume, to an external computing system, an expected waste volume of a waste portion of the fluid to be wasted; and a wasting station, including: a fluid injection port configured to be connected to the syringe and receive the waste portion of the fluid from the syringe; at least one sensor configured to capture wasting information associated with at least a wasted volume of the waste portion the fluid received from the syringe; and communication circuitry configured to communicate with the external computing system to at least one of receive, from the external computing system, the expected waste volume of the waste portion of the fluid and provide, to the external computing system, the wasting information; and at least one processor coupled to a memory and configured to: determine, based on the wasting information, the wasted volume of the waste portion the fluid received from the syringe; determine, based on the wasted volume and the expected waste volume, whether the wasted volume corresponds to the expected waste volume; and provide an indication of whether the wasted volume corresponds to the expected waste volume.

[0023] In some non-limiting embodiments or aspects, the external computing system includes the at least one processor coupled to the memory.

[0024] In some non-limiting embodiments or aspects, the wasting station includes the at least one processor coupled to the memory.

[0025] According to some non-limiting embodiments or aspects, provided is a method, including: receiving, with communication circuitry of a wasting station, from an external computing system, an expected waste volume of a waste portion of a fluid of a syringe; and receiving, with a fluid injection port of a wasting station, the waste portion of the fluid from the syringe; capturing, with at least one sensor of the wasting station, wasting information associated with at least a wasted volume of the waste portion the fluid received from the syringe; determining, with at least one processor, based on the wasting information, the wasted volume of the waste portion the fluid received from the syringe; determining, with the at least one processor, based on the wasted volume and the expected waste volume, whether the wasted volume corresponds to the expected waste volume; and providing, with the at least one processor, an indication of whether the wasted volume corresponds to the expected waste volume.

[0026] In some non-limiting embodiments or aspects, the method further includes: measuring, with a flow sensor, a delivered volume of a delivery portion of a fluid delivered from the syringe to a fluid pathway that provides the fluid to a patient; and providing, with the flow sensor, to the external computing system, based on the delivered volume, an expected waste volume of a waste portion of the fluid to be wasted.

[0027] In some non-limiting embodiments or aspects, receiving, from the external computing system, the expected waste volume of the waste portion of the fluid of the syringe further includes: reading, with a RFID reader of the wasting station, syringe information stored on a RFID tag on the syringe; and transmitting, with the communication circuitry of the wasting station, based on the syringe information, a request to the external computing system for the expected waste volume of the waste portion of the fluid.

[0028] In some non-limiting embodiments or aspects, the wasting information is further associated with a wasted drug and a wasted drug concentration of the waste portion the fluid received from the syringe, and wherein the method further includes: receiving, with the communication circuitry of the wasting station, from the external computing system, an expected drug and an expected drug concentration of the waste portion the fluid; determining, with the at least one processor, based on the wasting information, the wasted drug and the wasted drug concentration of the waste portion the fluid received from the syringe; determining, with the at least one processor, based on the wasted drug, the expected drug, the wasted drug concentration, and the expected drug concentration, whether the wasted drug corresponds to the expected drug and whether the wasted drug concentration corresponds to the expected drug concentration; and providing, with the at least one processor, an indication of whether the wasted drug corresponds to the expected drug and an indication of whether the wasted drug concentration corresponds to the expected drug concentration.

[0029] Further non-limiting embodiments or aspects are set forth in the following numbered clauses: [0030] Clause 1. An apparatus comprising: a fluid injection port configured to be connected to a syringe and receive a waste portion of a fluid from the syringe; at least one sensor configured to capture wasting information associated with at least a wasted volume of the waste portion the fluid received from the syringe; communication circuitry configured to communicate with an external computing system to receive an expected waste volume of the waste portion of the fluid; and at least one processor coupled to a memory and configured to: determine, based on the wasting information, the wasted volume of the waste portion of the fluid received from the syringe; determine, based on the wasted volume and the expected waste volume, whether the wasted volume corresponds to the expected waste volume; and provide an indication associated with receiving the waste portion of the fluid from the syringe.

[0031] Clause 2. The apparatus of clause 1, wherein the at least one sensor includes an external image capture device configured to capture, as the wasting information, a series of images of a moveable component of the syringe when the syringe is connected to the fluid injection port, and wherein the at least one processor is configured to determine the wasted volume by: processing, using one or more computer vision techniques, the series of images of the moveable component of the syringe.

[0032] Clause 3. The apparatus of clause 1 or clause 2, wherein the at least one sensor includes a mass balance scale configured to capture, as the wasting information, a wasted mass measurement of the waste portion the fluid received from the syringe, and wherein the at least one processor is configured to determine the wasted volume by: applying a mass balancing equation to the wasted mass measurement and a known density of the fluid.

[0033] Clause 4. The apparatus of any of clauses 1-3, wherein the wasting information is further associated with a wasted drug and a wasted drug concentration of the waste portion the fluid received from the syringe, wherein the communication circuitry is further configured to communicate with the external computing system to receive an expected drug and an expected drug concentration of the waste portion the fluid, and wherein the at least one processor is further configured to: determine, based on the wasting information, the wasted drug and the wasted drug concentration of the waste portion the fluid received from the syringe; determine, based on the wasted drug, the expected drug, the wasted drug concentration, and the expected drug concentration, whether the wasted drug corresponds to the expected drug and whether the wasted drug concentration corresponds to the expected drug concentration; and provide an indication of whether the wasted drug corresponds to the expected drug and an indication of whether the wasted drug concentration corresponds to the expected drug concentration. [0034] Clause 5. The apparatus of any of clauses 1-4, wherein the at least one sensor includes a spectroscopic sensor.

[0035] Clause 6. The apparatus of any of clauses 1-5, further comprising: a fluid path connected to the fluid injection port and including Raman spectroscopy head and a flowthrough-cell.

[0036] Clause 7. The apparatus of any of clauses 1-6, further comprising: a rotating or revolving element including a plurality of spectroscopy cuvettes spaced apart from each other around a circumference of the rotating or revolving element, wherein the rotating or revolving element is configured to rotate or revolve to introduce a spectroscopy cuvette of the plurality of spectroscopy cuvettes into the waste portion of the fluid received from the syringe.

[0037] Clause 8. The apparatus of any of clauses 1-7, wherein the at least one sensor includes an internal image capture device configured to capture an image of a test strip including a plurality of assays introduced into the waste portion of the fluid received from the syringe.

[0038] Clause 9. The apparatus of any of clauses 1-8, wherein the plurality of assays includes at least one of the following: one or more assays associated with a presence of one or more drugs, one or more assays associated with one or more predetermined concentrations of the one or more drugs, one or more assays associated with a presence of one or more diluents, one or more assays associated with one or more predetermined concentrations of the one or more diluents, or any combination thereof.

[0039] Clause 10. The apparatus of any of clauses 1-9, wherein the plurality of assays includes at least one of the following: a plurality of first assays associated with a plurality of different concentrations of a same drug, a plurality of second assays associated with a presence or one or more predetermined concentrations of a plurality of different drugs, a plurality of third assays associated with a plurality of different concentrations of a same diluent, a plurality of fourth assays associated with a presence or one or more predetermined concentrations of a plurality of different diluents, or any combination thereof.

[0040] Clause 11. The apparatus of any of clauses 1-10, further comprising: a rotating or revolving element including a plurality of test strips spaced apart from each other around a circumference of the rotating or revolving element, wherein the rotating or revolving element is configured to rotate or revolve to introduce the test strip into the waste portion of the fluid received from the syringe. [0041] Clause 12. The apparatus of any of clauses 1-11, further comprising: a pick roller configured to move the test strip from a top of a stack of test strips to introduce the test trip into the waste portion of the fluid received from the syringe.

[0042] Clause 13. The apparatus of any of clauses 1-12, further comprising: a RFID reader configured to read syringe information stored on a RFID tag on the syringe.

[0043] Clause 14. The apparatus of any of clauses 1-13, further comprising: a lockable housing, wherein the fluid injection port delivers the waste portion of the fluid received from the syringe to an interior of the lockable housing.

[0044] Clause 15. The apparatus of any of clauses 1-14, wherein the lockable housing further includes a neutralizing agent configured to neutralize the fluid.

[0045] Clause 16. The apparatus of any of clauses 1-15, further comprising: a user interface configured to receive user input from a user, wherein the at least one processor is configured to control the user interface to provide the indication associated with receiving the waste portion of the fluid from the syringe.

[0046] Clause 17. The apparatus of any of clauses 1-16, wherein the at least one processor is configured to control the communication circuitry to provide, to the external computing system, the indication associated with receiving the waste portion of the fluid from the syringe, and wherein the indication associated with receiving the waste portion of the fluid from the syringe includes an indication associated with whether the wasted volume corresponds to the expected waste volume.

[0047] Clause 18. A system comprising: a flow sensor configured to measure a delivered volume of a delivery portion of a fluid delivered from a syringe to a fluid pathway that provides the fluid to a patient and provide, based on the delivered volume, to an external computing system, an expected waste volume of a waste portion of the fluid to be wasted; and a wasting station, including: a fluid injection port configured to be connected to the syringe and receive the waste portion of the fluid from the syringe; at least one sensor configured to capture wasting information associated with at least a wasted volume of the waste portion the fluid received from the syringe; and communication circuitry configured to communicate with the external computing system to at least one of receive, from the external computing system, the expected waste volume of the waste portion of the fluid and provide, to the external computing system, the wasting information ; and at least one processor coupled to a memory and configured to: determine, based on the wasting information, the wasted volume of the waste portion the fluid received from the syringe; determine, based on the wasted volume and the expected waste volume, whether the wasted volume corresponds to the expected waste volume; and provide an indication of whether the wasted volume corresponds to the expected waste volume.

[0048] Clause 19. The system of clause 18, wherein the external computing system includes the at least one processor coupled to the memory.

[0049] Clause 20. The system of clause 18 or clause 19, wherein the wasting station includes the at least one processor coupled to the memory.

[0050] Clause 21. A method, comprising: receiving, with communication circuitry of a wasting station, from an external computing system, an expected waste volume of a waste portion of a fluid of a syringe; and receiving, with a fluid injection port of a wasting station, the waste portion of the fluid from the syringe; capturing, with at least one sensor of the wasting station, wasting information associated with at least a wasted volume of the waste portion the fluid received from the syringe; determining, with at least one processor, based on the wasting information, the wasted volume of the waste portion the fluid received from the syringe; determining, with the at least one processor, based on the wasted volume and the expected waste volume, whether the wasted volume corresponds to the expected waste volume; and providing, with the at least one processor, an indication of whether the wasted volume corresponds to the expected waste volume.

[0051] Clause 22. The method of clause 21, further comprising: measuring, with a flow sensor, a delivered volume of a delivery portion of a fluid delivered from the syringe to a fluid pathway that provides the fluid to a patient; and providing, with the flow sensor, to the external computing system, based on the delivered volume, an expected waste volume of a waste portion of the fluid to be wasted.

[0052] Clause 23. The method of clause 21 or clause 22, wherein receiving, from the external computing system, the expected waste volume of the waste portion of the fluid of the syringe further includes: reading, with a RFID reader of the wasting station, syringe information stored on a RFID tag on the syringe; and transmitting, with the communication circuitry of the wasting station, based on the syringe information, a request to the external computing system for the expected waste volume of the waste portion of the fluid.

[0053] Clause 24. The method of any of clauses 21-23, wherein the wasting information is further associated with a wasted drug and a wasted drug concentration of the waste portion the fluid received from the syringe, and wherein the method further comprises: receiving, with the communication circuitry of the wasting station, from the external computing system, an expected drug and an expected drug concentration of the waste portion the fluid; determining, with the at least one processor, based on the wasting information, the wasted drug and the wasted drug concentration of the waste portion the fluid received from the syringe; determining, with the at least one processor, based on the wasted drug, the expected drug, the wasted drug concentration, and the expected drug concentration, whether the wasted drug corresponds to the expected drug and whether the wasted drug concentration corresponds to the expected drug concentration; and providing, with the at least one processor, an indication of whether the wasted drug corresponds to the expected drug and an indication of whether the wasted drug concentration corresponds to the expected drug concentration.

[0054] These and other features and characteristics of the present disclosure, as well as the methods of operation and functions of the related elements of structures and the combination of parts and economies of manufacture, will become more apparent upon consideration of the following description and the appended claims with reference to the accompanying drawings, all of which form a part of this specification, wherein like reference numerals designate corresponding parts in the various figures. It is to be expressly understood, however, that the drawings are for the purpose of illustration and description only and are not intended as a definition of the limits of the disclosed subject matter.

BRIEF DESCRIPTION OF THE DRAWINGS

[0055] Additional advantages and details are explained in greater detail below with reference to the non-limiting, exemplary embodiments that are illustrated in the accompanying schematic figures, in which:

[0056] FIG. 1 is a schematic diagram of a system for controlled substance wasting, according to some non-limiting embodiments or aspects;

[0057] FIG. 2 is a schematic diagram of a wasting apparatus, according to some nonlimiting embodiments or aspects;

[0058] FIGS. 3 A and 3B illustrate images of syringes overlaid with corresponding masked images, according to some non-limiting embodiments or aspects;

[0059] FIG. 4 is a schematic diagram of an interior of a base of a wasting apparatus, according to some non-limiting embodiments or aspects;

[0060] FIG. 5 is a perspective view of an interior of a lid of a wasting apparatus including a spectroscopy sensor, according to some non-limiting embodiments or aspects;

[0061] FIGS. 6A and 6B are a side view and a perspective view, respectively, of an interior of a lid of a wasting apparatus including a carousel of spectroscopy cuvettes, according to some non-limiting embodiments or aspects; [0062] FIGS. 7A and 7B are perspective views of an interior of a lid of a wasting apparatus including a carousel of test strips, according to some non-limiting embodiments or aspects;

[0063] FIGS. 8A and 8B are side views of a pick roller for test strips, according to some non-limiting embodiments or aspects;

[0064] FIG. 9 is a schematic diagram of a test strip, according to some non-limiting embodiments or aspects;

[0065] FIG. 10 is a flow diagram of a method for controlled substance wasting, according to some non-limiting embodiments or aspects; and

[0066] FIG. 11 is a schematic diagram of example components of one or more devices of FIG. 1, according to some non-limiting embodiments or aspects.

DETAILED DESCRIPTION

[0067] For purposes of the description hereinafter, the terms “end,” “upper,” “lower,” “right,” “left,” “vertical,” “horizontal,” “top,” “bottom,” “lateral,” “longitudinal,” and derivatives thereof shall relate to the embodiments as they are oriented in the drawing figures. However, it is to be understood that the embodiments may assume various alternative variations and step sequences, except where expressly specified to the contrary. It is also to be understood that the specific devices and processes illustrated in the attached drawings, and described in the following specification, are simply exemplary embodiments or aspects of the disclosed subject matter. Hence, specific dimensions and other physical characteristics related to the embodiments or aspects disclosed herein are not to be considered as limiting.

[0068] It is to be understood that the present disclosure may assume various alternative variations and step sequences, except where expressly specified to the contrary. It is also to be understood that the specific devices and processes illustrated in the attached drawings, and described in the following specification, are simply exemplary and non-limiting embodiments or aspects. Hence, specific dimensions and other physical characteristics related to the embodiments or aspects disclosed herein are not to be considered as limiting.

[0069] Some non-limiting embodiments or aspects are described herein in connection with thresholds. As used herein, satisfying a threshold may refer to a value being greater than the threshold, more than the threshold, higher than the threshold, greater than or equal to the threshold, less than the threshold, fewer than the threshold, lower than the threshold, less than or equal to the threshold, equal to the threshold, etc.

[0070] No aspect, component, element, structure, act, step, function, instruction, and/or the like used herein should be construed as critical or essential unless explicitly described as such. Also, as used herein, the articles “a” and “an” are intended to include one or more items and may be used interchangeably with “one or more” and “at least one.” Furthermore, as used herein, the term “set” is intended to include one or more items (e.g., related items, unrelated items, a combination of related and unrelated items, and/or the like) and may be used interchangeably with “one or more” or “at least one.” Where only one item is intended, the term “one” or similar language is used. Also, as used herein, the terms “has,” “have,” “having,” or the like are intended to be open-ended terms. Further, the phrase “based on” is intended to mean “based at least partially on” unless explicitly stated otherwise. In addition, reference to an action being “based on” a condition may refer to the action being “in response to” the condition. For example, the phrases “based on” and “in response to” may, in some non-limiting embodiments or aspects, refer to a condition for automatically triggering an action (e.g., a specific operation of an electronic device, such as a computing device, a processor, and/or the like).

[0071] As used herein, the term “communication” may refer to the reception, receipt, transmission, transfer, provision, and/or the like of data (e.g., information, signals, messages, instructions, commands, and/or the like). For one unit (e.g., a device, a system, a component of a device or system, combinations thereof, and/or the like) to be in communication with another unit means that the one unit is able to directly or indirectly receive information from and/or transmit information to the other unit. This may refer to a direct or indirect connection (e.g., a direct communication connection, an indirect communication connection, and/or the like) that is wired and/or wireless in nature. Additionally, two units may be in communication with each other even though the information transmitted may be modified, processed, relayed, and/or routed between the first and second unit. For example, a first unit may be in communication with a second unit even though the first unit passively receives information and does not actively transmit information to the second unit. As another example, a first unit may be in communication with a second unit if at least one intermediary unit processes information received from the first unit and communicates the processed information to the second unit. In some non-limiting embodiments or aspects, a message may refer to a network packet (e.g., a data packet and/or the like) that includes data. It will be appreciated that numerous other arrangements are possible.

[0072] As used herein, the term “computing device” may refer to one or more electronic devices configured to process data. A computing device may, in some examples, include the necessary components to receive, process, and output data, such as a processor, a display, a memory, an input device, a network interface, and/or the like. A computing device may be a mobile device. As an example, a mobile device may include a cellular phone (e.g., a smartphone or standard cellular phone), a portable computer, a wearable device (e.g., watches, glasses, lenses, clothing, and/or the like), a personal digital assistant (PDA), and/or other like devices. A computing device may also be a desktop computer or other form of non-mobile computer.

[0073] As used herein, the term “server” may refer to or include one or more computing devices that are operated by or facilitate communication and processing for multiple parties in a network environment, such as the Internet, although it will be appreciated that communication may be facilitated over one or more public or private network environments and that various other arrangements are possible. Further, multiple computing devices (e.g., servers, point-of- sale (POS) devices, mobile devices, etc.) directly or indirectly communicating in the network environment may constitute a “system.” Reference to “a server” or “a processor,” as used herein, may refer to a previously-recited server and/or processor that is recited as performing a previous step or function, a different server and/or processor, and/or a combination of servers and/or processors. For example, as used in the specification and the claims, a first server and/or a first processor that is recited as performing a first step or function may refer to the same or different server and/or a processor recited as performing a second step or function.

[0074] As used herein, the term “system” may refer to one or more computing devices or combinations of computing devices (e.g., processors, servers, client devices, software applications, components of such, and/or the like). Reference to “a device,” “a server,” “a processor,” and/or the like, as used herein, may refer to a previously-recited device, server, or processor that is recited as performing a previous step or function, a different server or processor, and/or a combination of servers and/or processors. For example, as used in the specification and the claims, a first server or a first processor that is recited as performing a first step or a first function may refer to the same or different server or the same or different processor recited as performing a second step or a second function.

[0075] FIG. 1 is a schematic diagram of a system 100 for controlled substance wasting, according to some non-limiting embodiments or aspects. As shown in FIG. 1, system 100 may include wasting apparatus 102, flow sensor system 104, medical record system 106, and/or communication network 108.

[0076] Wasting apparatus 102 may include one or more devices capable of receiving information and/or data from flow sensor system 104 and/or medical record system 106 (e.g., via communication network 108, etc.) and/or communicating information and/or data to flow sensor system 104 and/or medical record system 106 (e.g., via communication network 108, etc.). For example, wasting apparatus 102 may include a computing device, such as a mobile device, a non-mobile devices, and/or other like devices. Further details regarding non-limiting embodiments or aspects of wasting apparatus 102 are described herein with respect to FIGS. 2-9.

[0077] Flow sensor system 104 may include one or more devices capable of receiving information and/or data from wasting apparatus 102 and/or medical record system 106 (e.g., via communication network 108, etc.) and/or communicating information and/or data to wasting apparatus 102 and/or medical record system 106 (e.g., via communication network 108, etc.). For example, flow sensor system 102 may include a computing device, such as a mobile device, a non-mobile devices, and/or other like devices.

[0078] Flow sensor system 104 may include a flow sensor configured to measure a delivered volume of a delivery portion of a fluid delivered from a syringe to a fluid pathway that provides the fluid to a patient and provide, based on the delivered volume, to an external computing system (e.g., to wasting apparatus 102, to medical record system 106, etc.), the delivered volume and/or an expected waste volume of a waste portion of the fluid to be wasted and/or syringe information associated with the fluid and/or the syringe. For example, the expected waste volume may be equal to an initial volume of a syringe minus the delivered volume. As an example, flow sensor system 104 may provide the expected waste volume in association with syringe information (e.g., a unique syringe identifier, etc.) associated with the fluid and/or the syringe used. In such an example, flow sensor system 104 may read the syringe information stored on an RFID tag on the syringe (e.g., read syringe information from RFID tag 205 on syringe 201 in FIG. 2, etc.)

[0079] In some non-limiting embodiments or aspects, flow sensor system 104 includes a flow sensor system as described by U.S. Provisional Patent Application No. 63/589,132, filed on October 10, 2023; U.S. Provisional Patent Application No. 63/589,115, filed on October 10, 2023; U.S. Nonprovisional Patent Application No. 17/159,310, filed on January 27, 2021, or any combination thereof, the contents of which are hereby incorporated by reference in their entireties.

[0080] Medical record system 106 may include one or more devices capable of receiving information and/or data from wasting apparatus 102 and/or flow sensor system 104 (e.g., via communication network 108, etc.) and/or communicating information and/or data to wasting apparatus 102 and/or flow sensor system 104 (e.g., via communication network 108, etc.). For example, medical record system 106 may include a computing device, such as a server, a group of servers, and/or other like devices. In some non-limiting embodiments or aspects, medical record system 106 may include an electronic medical record (EMR) system, a pharmacy information system (PIS), an anesthesia record system, and/or the like.

[0081] Communication Network 108 may include one or more wired and/or wireless networks. For example, communication network 108 may include a cellular network (e.g., a long-term evolution (LTE) network, a third generation (3G) network, a fourth generation (4G) network, a fifth generation (5G) network, a code division multiple access (CDMA) network, etc.), a public land mobile network (PLMN), a local area network (LAN), a wide area network (WAN), a metropolitan area network (MAN), a telephone network (e.g., the public switched telephone network (PSTN)), a private network, an ad hoc network, an intranet, the Internet, a fiber optic -based network, a cloud computing network, and/or the like, and/or a combination of these or other types of networks.

[0082] The number and arrangement of systems and devices shown in FIG. 1 is provided as an example. There can be additional systems and/or devices, fewer systems and/or devices, different systems and/or devices, or differently arranged systems and/or devices than those shown in FIG. 1. Furthermore, two or more systems or devices shown in FIG. 1 can be implemented within a single system or a single device, or a single system or a single device shown in FIG. 1 can be implemented as multiple, distributed systems or devices. Additionally, or alternatively, a set of systems or a set of devices (e.g., one or more systems, one or more devices, etc.) of system 100 can perform one or more functions described as being performed by another set of systems or another set of devices of system 100.

[0083] Referring now to FIG. 2, FIG. 2 is a schematic diagram of wasting apparatus 102, according to some non-limiting embodiments or aspects. Wasting apparatus 102 may include housing 202, fluid injection port 204, at least one sensor (e.g., external image capture device 206a, mass balance scale 206b, spectroscopic sensor 206c, internal image capture device 206d, etc.), communication circuitry (e.g., communication interface 1114 of FIG. 11, etc.), at least one processor coupled to a memory (e.g., processor 1104 and memory 1106 of FIG. 11, a microcontroller, etc.), user interface 208 (e.g., input component 1110 and output component 1112 of FIG. 11, a touchscreen display, etc.), and/or RFID reader 210.

[0084] Housing 202 may include lid 203a and base 203b. Lid 203a may be removably connected to base 203b. For example, housing 202 may include a lockable housing in which lid 203a may be locked in connection to base 203b to inhibit or prevent access to an interior of housing 202. Base 203b of housing 202 may include a neutralizing agent configured to neutralize a fluid received via fluid injection port 204 from syringe 201. For example, the neutralizing agent may be provided at a bottom of the interior of housing 202. [0085] Fluid injection port 204 may be located on lid 203a of housing 202. Fluid injection port 204 may be configured to be connected to syringe 201 and receive a waste portion of a fluid from syringe 201. For example, injection port 204 may include a luer connector configured to connect to a complementary luer connector on syringe 201. Fluid injection port may be configured to deliver or expel the waste portion of the fluid received from syringe 201 to the interior of housing 202. As an example, an interior of base 203b may be implemented as and/or include a container configured to collect the waste portion of the fluid received from syringe 201.

[0086] In some non-limiting embodiments or aspects, base 203b of housing 202 may be omitted or modified to enable a user to deliver the waste portion of the fluid received from syringe 201 to a suitable user-provided container or receptacle. For example, internal image capture device 206d, which is described herein in more detail with respect to FIG. 7A, (and/or another image capture device) may be configured with a field-of-view of a point of expulsion or outlet of fluid injection port 204 and/or an area to which the point of expulsion or outlet of fluid injection port 204 is directed for expelling the fluid to capture one or more images of the point of expulsion and/or the area (e.g., one or more images of the waste portion of the fluid received from syringe 201 being expelled from fluid injection port 204 to the area, etc.). The one or more images may be used to detect the user-provided container or receptacle into which the user is wasting to ensure wasting of hazardous material into an appropriate location. For example, the one or more images may be processed to identify a fiduciary on the user-provided container or receptacle (e.g., a QR code, a barcode, an icon, a color pattern, an AprilTag, etc.) and/or to perform identification of the wasting receptacle (e.g., using one or more object recognition techniques, etc.) to distinguish a suitable user-provided container or receptacle from inappropriate wasting locations or receptacles, such as drains, toilets, and/or the like. If an inappropriate wasting location or receptacle is identified as being used or attempted to be used for wasting, wasting apparatus may block flow of the fluid into and/or from fluid injection port (e.g., via automatic control of one or more valves within fluid injection port, etc.), generate an alert, and/or take other action to inhibit or prevent the inappropriate disposal.

[0087] The at least one sensor (e.g., external image capture device 206a, mass balance scale 206b, spectroscopic sensor 206c, internal image capture device 206d, etc.) of wasting apparatus 102 may be configured to capture wasting information associated with at least a wasted volume of the waste portion the fluid received from syringe 201.

[0088] Communication circuitry (e.g., communication interface 1114 of FIG. 11, etc.) may be configured to communicate with an external computing system (e.g., with flow sensor system 104, with medical record system 106, etc.) to receive an expected waste volume of the waste portion of the fluid. For example, communication circuitry (e.g., communication interface 1114 of FIG. 11, etc.) may include a transceiver-like component (e.g., a transceiver, a separate receiver and transmitter, etc.) that enables wasting apparatus 102 to communicate with other devices, such as via a wired connection, a wireless connection, or a combination of wired and wireless connections.

[0089] The at least one processor coupled to a memory (e.g., processor 1104 and memory 1106 of FIG. 11, a microcontroller, etc.) may be configured to determine, based on the wasting information, the wasted volume of the waste portion of the fluid received from the syringe; determine, based on the wasted volume and the expected waste volume, whether the wasted volume corresponds to (e.g., corresponds to, matches, is within a predetermined range of, etc.) the expected waste volume; and provide an indication (e.g., via user interface 208, etc.) of whether the wasted volume corresponds to the expected waste volume.

[0090] As used herein, the terms “correspond to” or “correspond with” encompasses a structural, functional, quantitative and/or qualitative correlation or relationship between two or more objects, data sets, information and/or the like, preferably where the correspondence or relationship may be used to translate one or more of the two or more objects, data sets, information and/or the like so to appear to be the same or equal. Correspondence may be assessed using one or more of a threshold or threshold difference, a value range, fuzzy logic, pattern matching, a machine learning assessment model, or combinations thereof.

[0091] User interface 208 (e.g., input component 1110 and output component 1112 of FIG. 11, a touchscreen display, etc.) may be configured to receive user input (e.g., a user identifier, a username and/or a password associated with a user, syringe information, patient information, etc.) from a user and/or to provide feedback (e.g., an indication associated with receiving a waste portion of a fluid, an indication associated with whether the wasted volume corresponds to the expected waste volume, etc.).

[0092] RFID reader 210 may be configured to read syringe information stored on RFID tag 205 on syringe 201. For example, RFID reader 104 may include a passive RFID reader, an active RFID reader, or any combination thereof. As shown in FIG. 2, RFID reader 210 may be integrated with lid 203a of housing 202 adjacent to fluid injection port 204. Syringe information may include a unique identifier associated with the fluid and/or syringe 201, a drug of the fluid, a concentration of the drug in the fluid, a volume of the fluid, a density of the fluid, any combination thereof, and/or the like. [0093] In some non-limiting embodiments or aspects, the at least one sensor of wasting apparatus 102 includes external image capture device 206a. External image capture device 206a may include one or more image capture devices (e.g., one or more cameras, one or more sensors, etc.) configured to capture one or more images of an environment surrounding the one or more image capture devices and/or wasting apparatus 102. For example, a field-of-view of external image capture device 206a may include syringe 201 when syringe 201 is connected to fluid injection port 204. As an example, external image capture device 206a may be configured to capture, as wasting information, a series of images of a moveable component (e.g., a stopper, a plunger rod, etc.) of syringe 201 when the syringe is connected to fluid injection port 204. As an example, external image capture device 206a may be configured to capture, as wasting information, one or more images of a user operating wasting apparatus 102. As an example, external image capture device 206a may be configured to capture, as wasting information, one or more images of a person witnessing a user operating wasting apparatus 102 (e.g., one or more images of a person witnessing a wasting of fluid from a syringe, etc.). As an example, external image capture device 206a may be configured to capture, as wasting information, one or more images of a label on syringe 201. As an example, external image capture device 206a may be configured to capture, as wasting information, one or more images of start graduation(s) and/or end graduation(s) on syringe 201. As an example, external image capture device 206a may be configured to capture, as wasting information, one or more images of syringe 201 being connected to wasting apparatus 102 and/or one or more images of syringe 201 being disconnected from wasting apparatus 102.

[0094] External image capture device 206a may include at least one of the following: a plurality of image capture devices, one or more light sources, a monocular camera, a stereo camera, a color camera configured to capture and/or detect one or more predetermined wavelengths of light, a camera including a filter configured to filter a predetermined wavelength of light, an infrared (IR) camera, a thermal sensor configured to capture thermal images of syringe 201 illuminated by infrared wavelengths of a light source, a pan, tilt, and zoom (PTZ) camera including a variable field-of-view (FOV) and an automatic zoom function, a master-slave camera system including a static camera and a dynamic camera, a LiDAR system, a RADAR system, and/or the like, or any combination thereof.

[0095] The at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to determine the wasted volume of the waste portion the fluid received from syringe 201 by processing, using one or more computer vision techniques, the series of images of the moveable component of syringe 201. For example, the one or more computer vision techniques may include one or more object recognition techniques, one or more color detection techniques, one or more motion detection techniques, one or more edge detection techniques, one or more machine learning techniques, any combination thereof, and/or the like. As an example, and referring also to FIGS. 3A and 3B, which illustrate images 300 and 350, respectively, of syringes overlaid with corresponding masked images, according to some non-limiting embodiments or aspects, a volume of the fluid dispensed from syringe 201 , a volume of the fluid remaining in syringe 201 , or any combination thereof may be determined in real-time using a masked image generated from segmenting a region of interest of an image of syringe 201 (which may be overlaid on that image of syringe 201 to visualize tracking of stopper and/or plunger of syringe 201 in real-time) as the stopper and/or plunger move relative to the syringe barrel over time in the series of images of syringe 201 as fluid is dispensed or wasted from syringe 201. In some non-limiting embodiments or aspects, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to determine the wasted volume of the waste portion the fluid received from syringe 201 using one or more of the systems and/or methods for tracking real-time syringe volume disclosed by U.S. Provisional Patent Application No. 63/509,607, filed on June 22, 2023, the content of which is hereby incorporated by reference in its entirety.

[0096] The at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to determine an anomaly event during a wasting operation by processing, using one or more computer vision techniques, the series of images of syringe 201. The at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to determine an identity of the user operating wasting apparatus 102 by processing, using the one or more computer vision techniques (e.g., one or more facial recognition techniques, etc.), the one or more images of the user operating wasting apparatus 102. The at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to determine an identity of the person witnessing the user operating wasting apparatus 102 by processing, using the one or more computer vision techniques (e.g., one or more facial recognition techniques, etc.), the one or more images of the person witnessing the user operating wasting apparatus 102. The at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to determine syringe information associated with a syringe by processing, using the one or more computer vision techniques, the one or more images of the label (e.g., a textual label, a barcode, a QR code, an AprilTag, etc.) on syringe 201. The at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to determine syringe information (e.g., an initial volume of the syringe, an unfilled volume of the syringe, a ending volume of the syringe, etc.) by processing, using the one or more computer vision techniques, the one or more images of the start graduation(s) and/or end graduation(s) on syringe 201. The at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to determine when syringe 201 is connected to wasting apparatus 102 and/or when syringe 201 is disconnected from wasting apparatus 102 by processing, using the one or more computer vision techniques, the one or more images of syringe 201 being connected to wasting apparatus 102 and/or the one or more images of syringe 201 being disconnected from wasting apparatus.

[0097] Referring also to FIG. 4, which is schematic diagram of an interior of a base of a wasting apparatus, according to some non-limiting embodiments or aspects, the at least one sensor of wasting apparatus 102 may include mass balance scale 206b. Mass balance scale 206b may be provided at a bottom of the interior of base 203b of housing 202. For example, fluid injection port 104 may be configured to deliver the waste portion the fluid received from syringe 201 onto mass balance scale 206. Mass balance scale 206b may be configured to capture, as wasting information, a wasted mass measurement of the waste portion the fluid received from syringe 201.

[0098] The at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to determine the wasted volume of the waste portion the fluid received from syringe 201 by applying a mass balancing equation to the wasted mass measurement and a known density of the fluid.

[0099] In some non-limiting embodiments or aspects, wasting information is further associated with a wasted drug and a wasted drug concentration of the waste portion the fluid received from syringe 201. For example, the at least one sensor (e.g., external image capture device 206a, mass balance scale 206b, spectroscopic sensor 206c, internal image capture device 206d, etc.) of wasting apparatus 102 may be further configured to capture wasting information associated with a wasted drug and a wasted drug concentration of the waste portion the fluid received from syringe 201. As an example, communication circuitry (e.g., communication interface 1114 of FIG. 11, etc.) may be configured to communicate with an external computing system (e.g., with flow sensor system 104, with medical record system 106, etc.) to receive an expected drug and an expected drug concentration of the waste portion the fluid. In such an example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be further configured to: determine, based on the wasting information, the wasted drug and the wasted drug concentration of the waste portion the fluid received from the syringe; determine, based on the wasted drug, the expected drug, the wasted drug concentration, and the expected drug concentration, whether the wasted drug corresponds to the expected drug and whether the wasted drug concentration corresponds to the expected drug concentration; and provide (e.g., via user interface 208, etc.) an indication of whether the wasted drug corresponds to the expected drug and an indication of whether the wasted drug concentration corresponds to the expected drug concentration.

[0100] Referring now to FIG. 5, FIG. 5 is a perspective view of an interior of a lid of a wasting apparatus including a spectroscopic sensor, according to some non-limiting embodiments or aspects. As shown in FIG. 5, the at least one sensor of wasting apparatus 102 may include spectroscopic sensor 206c. For example, spectroscopic sensor 206c may be configured to capture wasting information associated with a wasted drug and a wasted drug concentration of the waste portion the fluid received from syringe 201. As an example, wasting apparatus 102 may include a fluid path 502 connected to fluid injection port 204. For example, fluid path 502 may extend within an interior of housing 202 underneath lid 203 (e.g., extend from a side of lid 203a opposite another side of lid 203a from which fluid injection port 204 extends, etc.). Fluid path 502 may include Raman spectroscopy head and flow-through-cell 504 configured to capture wasting information associated with a wasted drug and a wasted drug concentration of the waste portion the fluid received from syringe 201 as the waste portion of the fluid flows through fluid path 502.

[0101] In some non-limiting embodiments or aspects, wasting apparatus 102 may include a rotating or revolving element including a plurality of spectroscopy cuvettes spaced apart from each other around a circumference of the rotating or revolving element. The rotating or revolving element may be configured to rotate or revolve to introduce (e.g., bring into contact with, etc.) a spectroscopy cuvette of the plurality of spectroscopy cuvettes into the waste portion of the fluid received from the syringe. For example, and referring now to FIGS. 6A and 6B, FIGS. 6A and 6B are a side view and a perspective view, respectively, of an interior of a lid of a wasting apparatus including a carousel of spectroscopy cuvettes, according to some non-limiting embodiments or aspects. As shown in FIGS. 6 A and 6B, wasting apparatus 102 may include wheel 602 including a plurality of spectroscopy cuvettes 604 spaced apart from each other around a circumference of wheel 602 (e.g., a rotatable wheel, a carousel, etc.). Wheel 602 may be configured to rotate to introduce a spectroscopy cuvette of the plurality of spectroscopy cuvettes 604 into the waste portion of the fluid received from syringe 201. For example, wasting apparatus 102 may include fluid path 606 connected to fluid injection port 204, and/or fluid path 606 may extend within an interior of housing 202 underneath lid 203a (e.g., extend from a side of lid 203a opposite another side of lid 203a from which fluid injection port 204 extends, etc.). As an example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to control a motor to rotate wheel 602 to move a spectroscopy cuvette of the plurality of spectroscopy cuvettes 604 adjacent and/or underneath a fluid outlet of fluid path 606 such that the waste portion of the fluid received from syringe 201 via fluid injection port 204 flows through fluid path 606 and into the spectroscopy cuvette of the plurality of spectroscopy cuvettes 604 moved to be adjacent and/or underneath the fluid outlet of fluid path 606. In such an example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may control rotation of the wheel such that the waste portion of the fluid may be directed above an opening of the cuvette to capture a sample if chemical analysis of the fluid is indicated by the syringe information or requested by the user or to let the fluid pass between cuvettes if chemical analysis not indicated by the syringe or information or requested by the user. The fluid samples in the cuvettes may be serially numbered by the at least one processor (e.g., processor 1104 of FIG. 11 , a microcontroller, etc.) of wasting apparatus 102 and/or kept locked in housing 202 until the fluid samples in the cuvettes can be collected by an administrator and/or taken to a central location for chemical analysis. For example, the drug and/or concentration of the retained samples may be verified and destroyed at the central location. [0102] Although described herein primarily with respect to carousel 602 of FIGS. 6 A and 6B, non-limiting embodiments or aspects a rotating or revolving element of wasting apparatus 102 configured to rotate or revolve to introduce a spectroscopy cuvette of the plurality of spectroscopy cuvettes into the waste portion of the fluid received from the syringe are not limited thereto, and non-limiting embodiments or aspects of a rotating or revolving element of wasting apparatus 102 configured to rotate or revolve to introduce a spectroscopy cuvette of the plurality of spectroscopy cuvettes into the waste portion of the fluid received from the syringe may include a conveyor system including the plurality of spectroscopy cuvettes spaced apart from each other along a belt, track, and/or chain configured to rotate or revolve around one or more pulleys or drums, a wheel system including the plurality of spectroscopy cuvettes spaced apart from each other around the wheel, and/or the like.

[0103] In some non-limiting embodiments or aspects, the at least one sensor of wasting apparatus 102 may include internal image capture device 206d. Internal image capture device 206d may include one or more image capture devices (e.g., one or more cameras, one or more sensors, etc.) configured to capture one or more images of a test strip introduced (e.g., introduced, brought into contact with, temporarily brought into contact with, etc.) into the waste portion of the fluid received from syringe 201. For example, a field-of-view of internal image capture device 206d may include the test strip when the test strip is introduced into a stream or path of droplets of the wasted fluid. As an example, internal image capture device 206d may be configured to capture, as wasting information, the image of the test strip after the test strip is introduced into the stream or path of droplets of the wasted fluid. The test strip may be locked in housing 202 such that the test strip cannot be tampered with until the wasting operation is over and the test strip is read by internal image capture device 206d. In such an example, external image capture device 206a may include at least one of the following: a plurality of image capture devices, a monocular camera, a stereo camera, a color camera configured to capture and/or detect one or more predetermined wavelengths of light, a camera including a filter configured to filter a predetermined wavelength of light, an infrared (IR) camera, a thermal sensor configured to capture thermal images of syringe 201 illuminated by infrared wavelengths of a light source, a pan, tilt, and zoom (PTZ) camera including a variable field-of-view (FOV) and an automatic zoom function, a master-slave camera system including a static camera and a dynamic camera, a LiDAR system, a RADAR system, and/or the like, or any combination thereof. The at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to determine the wasted drug and/or the wasted drug concentration of the waste portion the fluid received from syringe 201 by processing, using one or more computer vision techniques, the image of the test strip. For example, the one or more computer vision techniques may include one or more object recognition techniques, one or more color detection techniques, one or more edge detection techniques, one or more machine learning techniques, any combination thereof, and/or the like. As an example, the image may be processed to read or identify one or more assays or test lines on the test strip to determine a wasted drug, a wasted drug concentration, a diluent, and/or a diluent concentration of the waste portion the fluid received from syringe 201.

[0104] In some non-limiting embodiments or aspects, wasting apparatus 102 may include a rotating or revolving element including a plurality of test strips spaced apart from each other around a circumference of the rotating or revolving element. The rotating or revolving element may configured to rotate or revolve to introduce (e.g., bring into contact with, etc.) an individual test strip into the waste portion of the fluid received from the syringe. For example, and referring now to FIGS. 7A and 7B, FIGS. 7A and 7B are perspective views of an interior of a lid of a wasting apparatus including a carousel of test strips, according to some non-limiting embodiments or aspects. As shown in FIGS. 7A and 7B, wasting apparatus 102 may include wheel 702 including a plurality of test strips 704 spaced apart from each other around a circumference of wheel 702. Wheel 702 may be configured to rotate to introduce a test strip of the plurality of test strips 704 into the waste portion of the fluid received from syringe 201. For example, wasting apparatus 102 may include fluid path 706 connected to fluid injection port 204, and/or fluid path 706 may extend within an interior of housing 202 underneath lid 203a (e.g., extend from a side of lid 203a opposite another side of lid 203a from which fluid injection port 204 extends, etc.). As an example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to control a motor to rotate wheel 702 to move a test strip of the plurality of test strips adjacent and/or underneath a fluid outlet of fluid path 706 such that the waste portion of the fluid received from syringe 201 via fluid injection port 204 flows through fluid path 606 and onto the test strip of the plurality of test strips 704 moved to be adjacent and/or underneath the fluid outlet of fluid path 706. In such an example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may control rotation of wheel 702 such that the waste portion of the fluid may be directed above the test strip to introduce the test strip into the waste portion of the fluid if chemical analysis of the fluid is indicated by the syringe information or requested by the user or to let the fluid pass between test strips if chemical analysis not indicated by the syringe information or requested by the user.

[0105] Although described herein primarily with respect to carousel 702 of FIGS. 7 A and 7B, non-limiting embodiments or aspects a rotating or revolving element of wasting apparatus 102 configured to rotate or revolve to introduce an individual test strip into the waste portion of the fluid received from the syringe are not limited thereto, and non-limiting embodiments or aspects a rotating or revolving element of wasting apparatus 102 configured to rotate or revolve to introduce an individual test strip into the waste portion of the fluid received from the syringe may include a conveyor system including the plurality of test strips spaced apart from each other along a belt, track, and/or chain configured to rotate or revolve around one or more pulleys or drums, a wheel system including the plurality of test strips spaced apart from each other around the wheel, and/or the like.

[0106] Referring now to FIGS. 8A and 8B, FIGS. 8A and 8B are side views of a pick roller for test strips, according to some non-limiting embodiments or aspects. As shown in FIGS. 8A and 8B, wasting apparatus may include pick roller 802 and/or separation roller 808. Pick roller 802 may be configured to move a test strip from a top of a stack of test strips 804 to introduce the test trip into the waste portion of the fluid received from syringe 201. For example, wasting apparatus 102 may include a same or similar fluid path as fluid path 706 connected to fluid injection port 204 shown FIGS. 7A and 7B, which fluid path 706 may extend within an interior of housing 202 underneath lid 203a (e.g., extend from a side of lid 203a opposite another side of lid 203a from which fluid injection port 204 extends, etc.). As an example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may be configured to control a motor to rotate pick roller 802 to advance the test strip from the top of the stack of test strips 804 into the such that the waste portion of the fluid received from syringe 201 via fluid injection port 204 flows through fluid path 606 and onto the test strip. Separation roller 808 may be configured as a counter-rotating roller that singulates the top test strip by inhibiting or preventing additional test strips from advancing from the stack of test strips 804.

[0107] Referring now to FIG. 9, FIG. 9 is a schematic diagram of a test strip, according to some non-limiting embodiments or aspects. As shown in FIG. 9, test strip 900 may include a plurality of assays 902. For example, the plurality of assays 902 may include at least one of the following: one or more assays associated with a presence of one or more drugs, one or more assays associated with one or more predetermined concentrations of the one or more drugs, one or more assays associated with a presence of one or more diluents, one or more assays associated with one or more predetermined concentrations of the one or more diluents, or any combination thereof. As an example, the plurality of assays 902 may include at least one of the following: a plurality of first assays associated with a plurality of different concentrations of a same drug, a plurality of second assays associated with a presence or one or more predetermined concentrations of a plurality of different drugs, a plurality of third assays associated with a plurality of different concentrations of a same diluent, a plurality of fourth assays associated with a presence or one or more predetermined concentrations of a plurality of different diluents, or any combination thereof. In such an example, an assay may include a single waste use assay. For example, chemical assays and/or lateral flow immuno-assays may be used to detect drugs in minute quantities. As an example, the concentration of a drug in the wasted fluid may be detected by multiplexing a number of detection assays 902 onto test strip 900. Test strips 702 and/or 802 as described herein may be the same as or similar to test strip 900.

[0108] In this way, non-limiting embodiments or aspects of the present disclosure may provide for detecting multiple different concentrations of a same drug (and/or a same diluent) (e.g., to determine a concentration of a wasted drug and/or diluent, etc.) on an individual or single test strip and/or for detecting a presence (and/or one or more concentrations) of multiple different drugs (and/or diluents) on the individual or single test strip. [0109] Referring now to FIG. 10, shown is a flow diagram for a method 1000 for controlled substance wasting, according to some non-limiting embodiments or aspects. The steps shown in FIG. 10 are for example purposes only. It will be appreciated that additional, fewer, different, and/or a different order of steps may be used in some non-limiting embodiments or aspects. In some non-limiting embodiments or aspects, a step may be automatically performed in response to performance and/or completion of a prior step.

[0110] As shown in FIG. 10, at step 1002, method 1000 may include measuring a delivered volume of a delivery portion of a fluid delivered from the syringe to a fluid pathway that provides the fluid to a patient. For example, flow sensor system 104 may measure a delivered volume of a delivery portion of a fluid delivered from syringe 201 to a fluid pathway that provides the fluid to a patient.

[0111] As shown in FIG. 10, at step 1004, method 1000 may include providing, to an external computing system, based on the delivered volume, an expected waste volume of a waste portion of the fluid to be wasted. For example, flow sensor system 102 may provide, to medical record system 106, based on the delivered volume, an expected waste volume of a waste portion of the fluid to be wasted.

[0112] In some non-limiting embodiments or aspects, flow sensor system 102 (and/or another computing system, such as a medication dispensing system, a syringe labeling system, etc.) may provide, to medical record system 106, an expected drug and/or an expected drug concentration of the fluid in syringe 201. For example, medical record system 106 may store the expected waste volume, the expected drug, and/or the expected drug concentration of the waste portion of the fluid to be wasted in association with a unique identifier of syringe 201.

[0113] As shown in FIG. 10, at step 1006, method 1000 may include receiving, from an external computing system, an expected waste volume of a waste portion of a fluid of a syringe. For example, wasting apparatus 102 (e.g., communication circuitry of wasting apparatus 102, etc.) may receive, from medical record system 106, the expected waste volume of the waste portion of the fluid of syringe 201. As an example, wasting apparatus 102 (e.g., communication circuitry of wasting apparatus 102, etc.) may receive, from medical record system 106, the expected waste volume, the expected drug, and/or the expected drug concentration of the waste portion of the fluid to be wasted in association with a unique identifier of syringe 201.

[0114] In some non-limiting embodiments or aspects, receiving, from medical record system 106, the expected waste volume (and/or the expected drug and/or expected drug concentration) of the waste portion of the fluid of syringe 201 further includes: reading, with RFID reader 210 of wasting apparatus 102, syringe information stored on RFID tag 205 on syringe 201; and controlling, with the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102, based on the syringe information, communication circuitry (e.g., communication interface 1114 of FIG. 11, etc.) of wasting apparatus 102 to transmit a request to medical record system 106 for the expected waste volume (and/or the expected drug and/or expected drug concentration) of the waste portion of the fluid (e.g., a request including the unique identifier of syringe 201, etc.). For example, medical record system 106 may provide, to medical apparatus 102, the expected waste volume (and/or the expected drug and/or expected drug concentration) of the waste portion of the fluid of syringe 201, in response to receiving the request for the expected waste volume (and/or the expected drug and/or expected drug concentration) of the waste portion of the fluid.

[0115] In some non-limiting embodiments or aspects, receiving, from medical record system 106, the expected waste volume of the waste portion of the fluid of syringe 201 further includes: automatically receiving the expected waste volume (and/or the expected drug and/or expected drug concentration) of the waste portion of the fluid of syringe 201 in response to flow sensor system 104 measuring the delivered volume of the delivery portion of the fluid delivered from syringe 201 to the fluid pathway that provides the fluid to the patient and/or providing the expected waste volume of the waste portion of the fluid to be wasted to medical record system 106. For example, medical record system 106 (and/or flow sensor system 104) may automatically provide the expected waste volume of the waste portion of the fluid to be wasted to wasting apparatus 102.

[0116] As shown in FIG. 10, at step 1008, method 1000 may include receiving, with a fluid injection port of a wasting station, the waste portion of the fluid from the syringe. For example, wasting apparatus 104 may receive, via fluid injection port 204, the waste portion of the fluid from the syringe. As an example, the waste portion of the fluid may be manually wasted or pushed from the syringe into wasting apparatus 102 by a user. In such an example, the user may be verified by wasting apparatus 102 (e.g., via a username and password, via a unique identifier, etc.) though user interface 208 such that user information associated with the user (e.g., the unique identifier of the user, a user’s name, etc.) is stored in association with the syringe information and/or the wasting information associated with syringe 201 and/or the wasting event.

[0117] As shown in FIG. 10, at step 1010, method 1000 may include capturing wasting information associated with at least a wasted volume of the waste portion the fluid received from the syringe. For example, at least one sensor (e.g., external image capture device 206a, mass balance scale 206b, spectroscopic sensor 206c, internal image capture device 206d, etc.) of wasting apparatus 102 may capture wasting information associated with at least a wasted volume of the waste portion the fluid received from syringe 201.

[0118] In some non-limiting embodiments or aspects, the wasting information is further associated with a wasted drug and a wasted drug concentration of the waste portion the fluid received from the syringe. For example, the at least one sensor (e.g., external image capture device 206a, mass balance scale 206b, spectroscopic sensor 206c, internal image capture device 206d, etc.) of wasting apparatus 102 may capture wasting information associated with a wasted volume, a wasted drug, and/or a wasted drug concentration of the waste portion the fluid received from syringe 201. In some non-limiting embodiments or aspects, external image capture device 206a may additionally, or alternatively, record the wasting event.

[0119] In some non-limiting embodiments or aspects, the wasting information is further associated with a diluent level of the waste portion of the fluid received from the syringe (e.g., a presence, an amount, a level, a concentration, and/or a percentage of a diluent, such as saline, water, and/or another diluent, included in the waste portion of the fluid received from the syringe, etc.). For example, the at least one senor of wasting apparatus 102 may capture wasting information associated with a diluent level of the waste portion of the fluid received from the syringe. As an example, a user attempting to divert a drug may replace the diverted drug with an alternative fluid, such as saline, water, and/or another diluent.

[0120] In some non-limiting embodiments or aspects, a first wasting apparatus 104 may capture wasting information associated with a wasted volume of a waste portion a fluid received from a first portion of a plurality of syringes. The first wasting apparatus 104 may instruct a user to disconnect and retain a second portion (e.g., a randomly selected subset, etc.) of the plurality of syringes (before wasting at the first wasting apparatus 104) for chemical analysis at a central location, such as a second wasting apparatus 104. In such an example, the second wasting apparatus 104 may capture wasting information associated with a wasted volume, a wasted drug, and a wasted drug concentration of the waste portion the fluid received from syringe 201.

[0121] As shown in FIG. 10, at step 1012, method 1000 may include determining based on the wasting information, the wasted volume of the waste portion the fluid received from the syringe. For example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may determine, based on the wasting information, the wasted volume of the waste portion the fluid received from the syringe. As an example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may determine, based on the wasting information, the wasted volume, the wasted drug, the wasted drug concentration, and/or the diluent level of the waste portion the fluid received from the syringe.

[0122] As shown in FIG. 10, at step 1014, method 1000 may include determining, based on the wasted volume and the expected waste volume, whether the wasted volume corresponds to the expected waste volume. For example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may determine, based on the wasted volume and the expected waste volume, whether the wasted volume corresponds to the expected waste volume. As an example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may determine, based on the wasted drug, the expected drug, the wasted drug concentration, the expected drug concentration, and/or the diluent level whether the wasted drug corresponds to the expected drug and whether the wasted drug concentration corresponds to the expected drug concentration. In such an example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may compare the wasted volume to the expected wasted volume and/or compare measured chemical spectra and/or assay results of the waste portion of the fluid to chemical spectra of the fluid included in the syringe information.

[0123] As shown in FIG. 10, at step 1016, method 1000 may include providing an indication associated with receiving the waste portion of the fluid from the syringe. For example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may provide (e.g., via user interface 208, to medical record system 106, etc.) an indication associated with receiving the waste portion of the fluid from the syringe. As an example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may provide (e.g., via user interface 208, to medical record system 106, etc.) an indication that the waste portion of the fluid from the syringe has been received (e.g., received, measured, sequestered, etc.) by wasting apparatus 102. As an example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may provide an indication of whether the wasted volume corresponds to the expected waste volume, an indication of whether the wasted drug corresponds to the expected drug, and/or an indication of whether the wasted drug concentration corresponds to the expected drug concentration. In such an example, the at least one processor (e.g., processor 1104 of FIG. 11, a microcontroller, etc.) of wasting apparatus 102 may provide (e.g., via user interface 208, to medical record system 106, etc.) the indication(s) in association with the syringe information, the wasting information, and/or the like. [0124] Referring now to FIG. 11, shown is a diagram of example components of a device 1100 according to non-limiting embodiments. Device 1100 may correspond to wasting apparatus 102, flow sensor system 104, and/or medical record system 106, as an example. In some non-limiting embodiments, such systems or devices may include at least one device 1100 and/or at least one component of device 1100. The number and arrangement of components shown are provided as an example. In some non-limiting embodiments, device 1100 may include additional components, fewer components, different components, or differently arranged components than those shown. Additionally, or alternatively, a set of components (e.g., one or more components) of device 1100 may perform one or more functions described as being performed by another set of components of device 1100.

[0125] As shown in FIG. 11, device 1100 may include a bus 1102, a processor 1104, memory 1106, a storage component 1108, an input component 1110, an output component 1112, and a communication interface 1114. Bus 1102 may include a component that permits communication among the components of device 1100. In some non-limiting embodiments, processor 1104 may be implemented in hardware, firmware, or a combination of hardware and software. For example, processor 1104 may include a processor (e.g., a central processing unit (CPU), a graphics processing unit (GPU), an accelerated processing unit (APU), etc.), a microprocessor, a digital signal processor (DSP), and/or any processing component (e.g., a field-programmable gate array (FPGA), an application-specific integrated circuit (ASIC), etc.) that can be programmed to perform a function. Memory 1106 may include random access memory (RAM), read only memory (ROM), and/or another type of dynamic or static storage device (e.g., flash memory, magnetic memory, optical memory, etc.) that stores information and/or instructions for use by processor 1104.

[0126] With continued reference to FIG. 11, storage component 1108 may store information and/or software related to the operation and use of device 1100. For example, storage component 1108 may include a hard disk (e.g., a magnetic disk, an optical disk, a magneto-optic disk, a solid-state disk, etc.) and/or another type of computer-readable medium. Input component 1110 may include a component that permits device 1100 to receive information, such as via user input (e.g., a touch screen display, a keyboard, a keypad, a mouse, a button, a switch, a microphone, etc.). Additionally, or alternatively, input component 1110 may include a sensor for sensing information (e.g., a global positioning system (GPS) component, an accelerometer, a gyroscope, an actuator, etc.). Output component 1112 may include a component that provides output information from device 1100 (e.g., a display, a speaker, one or more light-emitting diodes (LEDs), etc.). Communication interface 1114 may include a transceiver-like component (e.g., a transceiver, a separate receiver and transmitter, etc.) that enables device 1100 to communicate with other devices, such as via a wired connection, a wireless connection, or a combination of wired and wireless connections. Communication interface 1114 may permit device 1100 to receive information from another device and/or provide information to another device. For example, communication interface 1114 may include an Ethernet interface, an optical interface, a coaxial interface, an infrared interface, a radio frequency (RF) interface, a universal serial bus (USB) interface, a Wi-Fi® interface, a cellular network interface, and/or the like.

[0127] Device 1100 may perform one or more processes described herein. Device 1100 may perform these processes based on processor 1104 executing software instructions stored by a computer-readable medium, such as memory 1106 and/or storage component 1108. A computer-readable medium may include any non-transitory memory device. A memory device includes memory space located inside of a single physical storage device or memory space spread across multiple physical storage devices. Software instructions may be read into memory 1106 and/or storage component 1108 from another computer-readable medium or from another device via communication interface 1114. When executed, software instructions stored in memory 1106 and/or storage component 1108 may cause processor 1104 to perform one or more processes described herein. Additionally, or alternatively, hardwired circuitry may be used in place of or in combination with software instructions to perform one or more processes described herein. Thus, embodiments described herein are not limited to any specific combination of hardware circuitry and software. The term “programmed or configured,” as used herein, refers to an arrangement of software, hardware circuitry, or any combination thereof on one or more devices.

[0128] Although embodiments have been described in detail for the purpose of illustration, it is to be understood that such detail is solely for that purpose and that the disclosure is not limited to the disclosed embodiments or aspects, but, on the contrary, is intended to cover modifications and equivalent arrangements that are within the spirit and scope of the appended claims. For example, it is to be understood that the present disclosure contemplates that, to the extent possible, one or more features of any embodiment or aspect can be combined with one or more features of any other embodiment or aspect.

Claims

WHAT IS CLAIMED IS:

1. An apparatus, comprising: a fluid injection port configured to be connected to a syringe and receive a waste portion of a fluid from the syringe; at least one sensor configured to capture wasting information associated with at least a wasted volume of the waste portion the fluid received from the syringe; communication circuitry configured to communicate with an external computing system to receive an expected waste volume of the waste portion of the fluid; and at least one processor coupled to a memory and configured to: determine, based on the wasting information, the wasted volume of the waste portion of the fluid received from the syringe; determine, based on the wasted volume and the expected waste volume, whether the wasted volume corresponds to the expected waste volume; and provide an indication associated with receiving the waste portion of the fluid from the syringe.

2. The apparatus of claim 1, wherein the at least one sensor includes an external image capture device configured to capture, as the wasting information, a series of images of a moveable component of the syringe when the syringe is connected to the fluid injection port, and wherein the at least one processor is configured to determine the wasted volume by: processing, using one or more computer vision techniques, the series of images of the moveable component of the syringe.

3. The apparatus of claim 1, wherein the at least one sensor includes a mass balance scale configured to capture, as the wasting information, a wasted mass measurement of the waste portion the fluid received from the syringe, and wherein the at least one processor is configured to determine the wasted volume by: applying a mass balancing equation to the wasted mass measurement and a known density of the fluid.

4. The apparatus of claim 1, wherein the wasting information is further associated with a wasted drug and a wasted drug concentration of the waste portion the fluid received from the syringe, wherein the communication circuitry is further configured to communicate with the external computing system to receive an expected drug and an expected drug concentration of the waste portion the fluid, and wherein the at least one processor is further configured to: determine, based on the wasting information, the wasted drug and the wasted drug concentration of the waste portion the fluid received from the syringe; determine, based on the wasted drug, the expected drug, the wasted drug concentration, and the expected drug concentration, whether the wasted drug corresponds to the expected drug and whether the wasted drug concentration corresponds to the expected drug concentration; and provide an indication of whether the wasted drug corresponds to the expected drug and an indication of whether the wasted drug concentration corresponds to the expected drug concentration.

5. The apparatus of claim 4, wherein the at least one sensor includes a spectroscopic sensor.

6. The apparatus of claim 5, further comprising: a fluid path connected to the fluid injection port and including Raman spectroscopy head and a flow-through-cell.

7. The apparatus of claim 1, further comprising: a rotating or revolving element including a plurality of spectroscopy cuvettes spaced apart from each other around a circumference of the rotating or revolving element, wherein the rotating or revolving element is configured to rotate or revolve to introduce a spectroscopy cuvette of the plurality of spectroscopy cuvettes into the waste portion of the fluid received from the syringe.

8. The apparatus of claim 4, wherein the at least one sensor includes an internal image capture device configured to capture an image of a test strip including a plurality of assays introduced into the waste portion of the fluid received from the syringe.

9. The apparatus of claim 8, wherein the plurality of assays includes at least one of the following: one or more assays associated with a presence of one or more drugs, one or more assays associated with one or more predetermined concentrations of the one or more drugs, one or more assays associated with a presence of one or more diluents, one or more assays associated with one or more predetermined concentrations of the one or more diluents, or any combination thereof.

10. The apparatus of claim 8, wherein the plurality of assays includes at least one of the following: a plurality of first assays associated with a plurality of different concentrations of a same drug, a plurality of second assays associated with a presence or one or more predetermined concentrations of a plurality of different drugs, a plurality of third assays associated with a plurality of different concentrations of a same diluent, a plurality of fourth assays associated with a presence or one or more predetermined concentrations of a plurality of different diluents, or any combination thereof.

11. The apparatus of claim 8, further comprising: a rotating or revolving element including a plurality of test strips spaced apart from each other around a circumference of the rotating or revolving element, wherein the rotating or revolving element is configured to rotate or revolve to introduce the test strip into the waste portion of the fluid received from the syringe.

12. The apparatus of claim 8, further comprising: a pick roller configured to move the test strip from a top of a stack of test strips to introduce the test trip into the waste portion of the fluid received from the syringe.

13. The apparatus of claim 1, further comprising: a RFID reader configured to read syringe information stored on a RFID tag on the syringe.

14. The apparatus of claim 1, further comprising: a lockable housing, wherein the fluid injection port delivers the waste portion of the fluid received from the syringe to an interior of the lockable housing.

15. The apparatus of claim 14, wherein the lockable housing further includes a neutralizing agent configured to neutralize the fluid.

16. The apparatus of claim 1, further comprising: a user interface configured to receive user input from a user, wherein the at least one processor is configured to control the user interface to provide the indication associated with receiving the waste portion of the fluid from the syringe.

17. The apparatus of claim 1, wherein the at least one processor is configured to control the communication circuitry to provide, to the external computing system, the indication associated with receiving the waste portion of the fluid from the syringe, and wherein the indication associated with receiving the waste portion of the fluid from the syringe includes an indication associated with whether the wasted volume corresponds to the expected waste volume.

18. A system, comprising: a flow sensor configured to measure a delivered volume of a delivery portion of a fluid delivered from a syringe to a fluid pathway that provides the fluid to a patient and provide, based on the delivered volume, to an external computing system, an expected waste volume of a waste portion of the fluid to be wasted; and a wasting station, including: a fluid injection port configured to be connected to the syringe and receive the waste portion of the fluid from the syringe; at least one sensor configured to capture wasting information associated with at least a wasted volume of the waste portion the fluid received from the syringe; and communication circuitry configured to communicate with the external computing system to at least one of receive, from the external computing system, the expected waste volume of the waste portion of the fluid and provide, to the external computing system, the wasting information ; and at least one processor coupled to a memory and configured to: determine, based on the wasting information, the wasted volume of the waste portion the fluid received from the syringe; determine, based on the wasted volume and the expected waste volume, whether the wasted volume corresponds to the expected waste volume; and provide an indication of whether the wasted volume corresponds to the expected waste volume.

19. The system of claim 18, wherein the external computing system includes the at least one processor coupled to the memory.

20. The system of claim 18, wherein the wasting station includes the at least one processor coupled to the memory.